{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:10:18Z","timestamp":1760037018683,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Domestic Animal Endocrinology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.domaniend.2012.09.003","type":"journal-article","created":{"date-parts":[[2012,9,29]],"date-time":"2012-09-29T01:16:08Z","timestamp":1348881368000},"page":"70-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Oxyntomodulin attenuates exendin-4-induced hypoglycemia in cattle"],"prefix":"10.1016","volume":"44","author":[{"given":"S.","family":"ThanThan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Asada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Ochiiwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Yannaing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Kuwayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.domaniend.2012.09.003_bib1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0140-6736(65)90761-0","article-title":"Promotion of insulin secretion by glucagon","volume":"2","author":"Samols","year":"1965","journal-title":"Lancet"},{"key":"10.1016\/j.domaniend.2012.09.003_bib2","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1016\/S0021-9258(19)45235-6","article-title":"The regulation of gluconeogenesis in isolated rat liver cells by glucagon, insulin, dibutyryl cyclic adenosine monophosphate, and fatty acids","volume":"247","author":"Johnson","year":"1972","journal-title":"J Biol Chem"},{"key":"10.1016\/j.domaniend.2012.09.003_bib3","series-title":"Glucagon: Its Role in Physiology and Clinical Medicine","first-page":"287","article-title":"Interaction of hepatocyte membrane receptors with pancreatic and gut glucagon","author":"Holst","year":"1977"},{"key":"10.1016\/j.domaniend.2012.09.003_bib4","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1210\/endo-115-1-102","article-title":"A pure enteroglucagon, oxyntomodulin (glucagon 37), stimulates insulin release in perfused rat pancreas","volume":"115","author":"Jarrousse","year":"1984","journal-title":"Endocrinology"},{"key":"10.1016\/j.domaniend.2012.09.003_bib5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.domaniend.2010.05.001","article-title":"Oxyntomodulin increases the concentrations of insulin and glucose in plasma but does not affect ghrelin secretion in Holstein cattle under normal physiological conditions","volume":"39","author":"ThanThan","year":"2010","journal-title":"Domest Anim Endocrinol"},{"key":"10.1016\/j.domaniend.2012.09.003_bib6","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1053\/gast.1997.v112.pm9178688","article-title":"Oxyntomodulin stimulates intestinal glucose uptake in rats","volume":"112","author":"Collie","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.domaniend.2012.09.003_bib7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0014-5793(97)00628-5","article-title":"A new role for enteric glucagon-37: acute stimulation of glucose absorption in rat small intestine","volume":"410","author":"St\u00fcmpel","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1016\/j.domaniend.2012.09.003_bib8","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1053\/j.gastro.2004.04.063","article-title":"Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure","volume":"127","author":"Baggio","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.domaniend.2012.09.003_bib9","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/ncpendmet0318","article-title":"The role of oxyntomodulin and peptide tyrosine-tyrosine (PYY) in appetite control","volume":"2","author":"Wynne","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.domaniend.2012.09.003_bib10","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1210\/en.2001-210979","article-title":"Transfection of pancreatic-derived beta-cells with a minigene encoding for human glucagon-like peptide-1 regulates glucose-dependent insulin synthesis and secretion","volume":"143","author":"Hui","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.domaniend.2012.09.003_bib11","doi-asserted-by":"crossref","first-page":"270","DOI":"10.2337\/diacare.15.2.270","article-title":"Insulinotropic action of glucagonlike peptide-I-(7-37) in diabetic and nondiabetic subjects","volume":"15","author":"Nathan","year":"1992","journal-title":"Diabetes Care"},{"key":"10.1016\/j.domaniend.2012.09.003_bib12","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/BF00401145","article-title":"Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients","volume":"36","author":"Nauck","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/j.domaniend.2012.09.003_bib13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1385\/ENDO:15:2:241","article-title":"Effect of GLP-1 treatment on GLUT2 and GLUT4 expression in type 1 and type 2 rat diabetic models","volume":"15","author":"Villanueva-Pe\u00f1acarrillo","year":"2001","journal-title":"Endocrine"},{"key":"10.1016\/j.domaniend.2012.09.003_bib14","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1210\/en.2011-0259","article-title":"Glucagon-like peptide-1 enhances glucokinase activity in pancreatic \u03b2-cells through the association of Epac2 with Rim2 and Rab3A","volume":"153","author":"Park","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.domaniend.2012.09.003_bib15","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1210\/endo.136.8.7628397","article-title":"Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV","volume":"136","author":"Kieffer","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.domaniend.2012.09.003_bib16","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1210\/jc.2002-021053","article-title":"Similar elimination rates of glucagon-like peptide-1 in obese type 2 diabetic patients and healthy subjects","volume":"88","author":"Vilsb\u00f8ll","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.domaniend.2012.09.003_bib17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/ajhp\/62.2.173","article-title":"Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus","volume":"62","author":"Kolterman","year":"2005","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.domaniend.2012.09.003_bib18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00125-001-0719-z","article-title":"The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men","volume":"45","author":"Agers\u00f8","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.domaniend.2012.09.003_bib19","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.1016\/S0021-9258(18)42531-8","article-title":"Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom","volume":"267","author":"Eng","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.domaniend.2012.09.003_bib20","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1053\/meta.2001.22519","article-title":"Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro","volume":"50","author":"Parkes","year":"2001","journal-title":"Metabolism"},{"key":"10.1016\/j.domaniend.2012.09.003_bib21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s001250051111","article-title":"Once daily injection of exendin-4 to diabetic mice achieves long-term beneficial effects on blood glucose concentrations","volume":"42","author":"Greig","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/j.domaniend.2012.09.003_bib22","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.2337\/diacare.26.8.2370","article-title":"Effect on glycemic control of exenatide (synthetic exendin-4) additive to existing metformin and\/or sulfonylurea treatment in patients with type 2 diabetes","volume":"26","author":"Fineman","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.domaniend.2012.09.003_bib23","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.2337\/diabetes.50.7.1562","article-title":"Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age","volume":"50","author":"Tourrel","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.domaniend.2012.09.003_bib24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.regpep.2008.08.005","article-title":"Effect of exendin-4 treatment upon glucose uptake parameters in rat liver and muscle, in normal and type 2 diabetic state","volume":"153","author":"Arn\u00e9s","year":"2009","journal-title":"Regul Pept"},{"key":"10.1016\/j.domaniend.2012.09.003_bib25","doi-asserted-by":"crossref","DOI":"10.1111\/j.1753-0407.2012.00193.x","article-title":"Exendin-4 activates glucokinase","author":"Dhanesha","year":"2012","journal-title":"J Diabetes"},{"key":"10.1016\/j.domaniend.2012.09.003_bib26","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1463-1326.2011.01428.x","article-title":"Effects of exenatide twice daily versus sitagliptin on 24-h glucose, glucoregulatory and hormonal measures: a randomized, double-blind, crossover study","volume":"13","author":"Berg","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.domaniend.2012.09.003_bib27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.domaniend.2011.11.004","article-title":"Glucagon-like peptide-1 inhibits insulinotropic effects of oxyntomodulin and glucagon in cattle","volume":"42","author":"ThanThan","year":"2012","journal-title":"Domest Anim Endocrinol"},{"key":"10.1016\/j.domaniend.2012.09.003_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.domaniend.2009.07.007","article-title":"Endogenous ghrelin released in response to endothelin stimulates growth hormone secretion in cattle","volume":"38","author":"ThanThan","year":"2010","journal-title":"Domest Anim Endocrinol"},{"key":"10.1016\/j.domaniend.2012.09.003_bib29","series-title":"Methods in Enzymology","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0076-6879(80)70050-2","article-title":"Radioiodination of proteins by the use of the chloramine-T method","author":"McConahey","year":"1980"},{"key":"10.1016\/j.domaniend.2012.09.003_bib30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/0003-2697(75)90562-X","article-title":"Preparation of 125I-labeled secretin of high specific radioactivity","volume":"69","author":"Tai","year":"1975","journal-title":"Anal Biochem"},{"key":"10.1016\/j.domaniend.2012.09.003_bib31","doi-asserted-by":"crossref","first-page":"20259","DOI":"10.1016\/S0021-9258(17)30498-2","article-title":"Purification and structure of exendin-3, a new pancreatic secretagogue isolated from Heloderma horridum venom","volume":"265","author":"Eng","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1016\/j.domaniend.2012.09.003_bib32","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0196-9781(94)90204-6","article-title":"Stable expression of the rat GLP-I receptor in CHO cells: activation and binding characteristics utilizing GLP-I(7-36)-amide, oxyntomodulin, exendin-4, and exendin(9-39)","volume":"15","author":"Fehmann","year":"1994","journal-title":"Peptides"},{"key":"10.1016\/j.domaniend.2012.09.003_bib33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0167-0115(88)90099-7","article-title":"Oxyntomodulin (glicentin-(33-69)): pharmacokinetics, binding to liver cell membranes, effects on isolated perfused pig pancreas, and secretion from isolated perfused lower small intestine of pigs","volume":"21","author":"Baldissera","year":"1988","journal-title":"Regul Pept"},{"key":"10.1016\/j.domaniend.2012.09.003_bib34","doi-asserted-by":"crossref","first-page":"E142","DOI":"10.1152\/ajpendo.00576.2007","article-title":"Oxyntomodulin ameliorates glucose intolerance in mice fed a high-fat diet","volume":"294","author":"Parlevliet","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.domaniend.2012.09.003_bib35","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.domaniend.2011.03.001","article-title":"The GLP-1 mimetic exenatide potentiates insulin secretion in healthy cats","volume":"41","author":"Gilor","year":"2011","journal-title":"Domest Anim Endocrinol"},{"key":"10.1016\/j.domaniend.2012.09.003_bib36","doi-asserted-by":"crossref","first-page":"21201","DOI":"10.1074\/jbc.272.34.21201","article-title":"High potency antagonists of the pancreatic glucagon-like peptide-1 receptor","volume":"272","author":"Montrose-Rafizadeh","year":"1997","journal-title":"J Biol Chem"}],"container-title":["Domestic Animal Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0739724012001397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0739724012001397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:50:44Z","timestamp":1760035844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0739724012001397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0739724012001397"],"URL":"https:\/\/doi.org\/10.1016\/j.domaniend.2012.09.003","relation":{},"ISSN":["0739-7240"],"issn-type":[{"type":"print","value":"0739-7240"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxyntomodulin attenuates exendin-4-induced hypoglycemia in cattle","name":"articletitle","label":"Article Title"},{"value":"Domestic Animal Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.domaniend.2012.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}